TNFRSF11B and nephrolithiasis: This hypothesis implies that the increased circulating OPG levels in nephrolithiasis patients with reduced BMD may be a compensatory mechanism against other factors that promote bone damages [14], perhaps as a part of response to inflammation in nephrolithiasis.